Solitary Fibrous Tumor, Pleural clinical trials
The registry lists 27 studies for Solitary Fibrous Tumor, Pleural across 7 countries. 0 are recruiting or about to start. 1 of them are mainly about Solitary Fibrous Tumor, Pleural (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.
Who runs them
National Cancer Institute (NCI) (11) · Alliance for Clinical Trials in Oncology (5) · Mayo Clinic (3) · The Cleveland Clinic (1) · University of Chicago (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · SWOG Cancer Research Network (1) · Papworth Hospital NHS Foundation Trust (1)
What is being tested here
Drugs under test in Solitary Fibrous Tumor, Pleural studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Cediranib | 0 | 0 | 3 |
| Cisplatin | 0 | 0 | 2 |
| Pemetrexed | 0 | 0 | 2 |
| Pembrolizumab | 0 | 0 | 1 |
| Methotrexate | 0 | 0 | 1 |
| Vinorelbine | 0 | 0 | 1 |
| Belinostat | 0 | 0 | 1 |
| Dasatinib | 0 | 0 | 1 |
| Capecitabine | 0 | 0 | 1 |
| Vatalanib | 0 | 0 | 1 |
Drug classes tested here Tyrosine kinase inhibitors (TKIs) 10 · Antimetabolites 5
Who these studies take
No Solitary Fibrous Tumor, Pleural study is recruiting now.
Across all 27 studies, recruiting or not: 11% stop at 75 or younger and 0% at 65; 15% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 27 of 27. search them.
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural MesotheliomaActive, not recruitingNCT01064648Phase 1/21 country
- Pembrolizumab in Treating Patients With Malignant MesotheliomaCompletedNCT02399371Phase 21 country
- Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural MesotheliomaCompletedNCT00354393Phase 21 country
- Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural MesotheliomaTerminatedNCT026132991 country
- Staging Procedures to Diagnose Malignant Pleural MesotheliomaTerminatedNCT026487631 country
- Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural MesotheliomaTerminatedNCT026133121 country
- Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line ChemotherapyCompletedNCT01085630Phase 21 country
- Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00334594Phase 22 countries
- Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107TerminatedNCT00898547
- PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By SurgeryCompletedNCT00365053Phase 21 country
- S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By SurgeryCompletedNCT00243074Phase 21 country
- Tivantinib in Treating Patients With Previously Treated Malignant MesotheliomaTerminatedNCT01861301Phase 21 country
- Dasatinib in Treating Patients With Previously Treated Malignant MesotheliomaCompletedNCT00509041Phase 21 country
- Capecitabine in Treating Patients With Malignant MesotheliomaCompletedNCT00004183Phase 21 country
- PTK787/ZK 222584 in Treating Patients With Unresectable Malignant MesotheliomaCompletedNCT00053885Phase 21 country
- Epidemiology and Outcome of Solitary Fibrous Tumors of the Pleura.Status unknownNCT016946541 country
- Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryCompletedNCT00309946Phase 21 country
- Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant MesotheliomaCompletedNCT00027703Phase 21 country
- AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaWithdrawnNCT01105390Phase 2
- Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant MesotheliomaCompletedNCT00821860Phase 31 country
- Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.CompletedNCT00107432Phase 21 country
- SU5416 in Treating Patients With Malignant MesotheliomaCompletedNCT00006014Phase 21 country
- Erlotinib in Treating Patients With Malignant Mesothelioma of the LungCompletedNCT00039182Phase 21 country
- Gefitinib in Treating Patients With Malignant MesotheliomaCompletedNCT00025207Phase 21 country
- S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by SurgeryCompletedNCT00003723Phase 21 country
- Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00227630Phase 24 countries
- Surgery and Photodynamic Therapy in Treating Patients With Malignant MesotheliomaCompletedNCT00054002Phase 21 country